Skip to search.
 TSX Up 2.88% TSX Ventures Up 2.99%

BioCryst Pharmaceuticals, Inc. (BCRX)

-NasdaqGS
11.21 Up 0.23(2.09%) Aug 27, 4:00PM EDT
Add to Portfolio
Prev Close:10.98
Open:11.10
Bid:10.01 x 1000
Ask:11.65 x 300
1y Target Est:18.00
Beta:3.58544
Next Earnings Date: 5-Nov-15BCRX Earnings announcement
Day's Range:11.01 - 11.56
52wk Range:7.85 - 16.83
Volume:583,538
Avg Vol (3m):1,033,040
Market Cap:821.01M
P/E (ttm):N/A
EPS (ttm):-0.43
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BCRXUp 2.09%821.01M
GSKUp 1.83%99.60B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):19.45
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.64
Quarterly EPS Est (Sep-15) :-0.22
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):0.77

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule drugs that block key enzymes involved in the pathogenesis of diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback